Documentation Centre

November 06, 2018
Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy. Circulation. 2018;138:141-149
Pradhan AD, Aday AW, Rose LM, Ridker PM

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiovascular Disease, Inflammation, Lipids/Lipoproteins